FORMAS CRISTALINAS DE [3-(4-{2-BUTIL-1-[4-(4-CLORO-FENOXI)-FENIL]1H-IMIDAZOL-4-IL}-FENOXI)-PROPIL]-DIETIL-AMINA; PROCEDIMIENTO DE PREPARACION, UTIL PARA TRATAR ENFERMEDADES MEDIADAS POR RAGE, TALES COMO ALZHEIMER, CANCER, INFLAMACION AGUDA Y CRONICA,

摘要

The present invention relates to crystalline forms of [3-(4-{2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1H-imidazol-4-yl}-phenoxy)-propyl]-diethylamine (“COMPOUND I”) useful in the treatment of RAGE mediated diseases.